Advancements in Liver Fibrosis: Diagnostics to Personalized Care
Abstract
Liver fibrosis research is advancing, focusing on noninvasive diagnostics, including serological markers and imaging, to personalize patient care [1]. Key areas involve understanding inflammation and Non-Alcoholic Fatty Liver Disease (NAFLD)/Non-Alcoholic Steatohepatitis (NASH) in driving fibrosis, alongside exploring novel molecular, epigenetic, and gut microbiota-targeted therapies [2, 3, 4, 6, 8]. Biomarkers, Artificial Intelligence (AI), and single-cell sequencing are enhancing diagnostic precision and unraveling cellular complexities [5, 7, 9]. Despite ongoing challenges, future perspectives emphasize personalized medicine and integrated advanced technologies to improve management outcomes
Citation:
Copyright:
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 305
- [From(publication date): 0-0 - Apr 11, 2026]
- Breakdown by view type
- HTML page views: 203
- PDF downloads: 102
